Higher Living with Chad

Can Clinics Make Money? | EP 49

6 min · 23 de jun de 2025
Portada del episodio Can Clinics Make Money? | EP 49

Descripción

In this episode of Higher Living, Chad dives into the rising buzz around clinics in Australia’s changing healthcare space. It’s been a big week of news, with Incannex Healthcare announcing a joint venture with Mind Medicine Australia, and Emyria landing a funding deal with Medibank. Clinics are back in the spotlight. But if they’re not turning a profit, why is everyone so eager to build or support them? From CDA Clinics and Montu to Eucalyptus and their proprietary tech, we take a closer look at what’s really driving the boom. Is it the prescriptions? The patient services? Or is it all about the strategy? Chad also breaks down two key models of vertical integration: owning the medications, or partnering with multiple suppliers. Each approach has major implications for patient access and long-term clinic sustainability. So, is there actually money in clinics or are we missing something bigger?

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Higher Living with Chad!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

48 episodios

episode CBD vs THC: A Case Study in Dosing and Effects | EP 51 artwork

CBD vs THC: A Case Study in Dosing and Effects | EP 51

What happens when you take an extended break from THC? In this episode, Chad shares his personal 30-day reset experience, comparing CBD (60–80mg) with prior THC use and reflecting on what’s changed since he started doing these annual resets back in 2018.We cover:Symptom relief on CBD vs THCLonger onset and therapeutic window with CBDReduced cravings and stress spikes compared to earlier breaksObserved differences in muscle soreness, sleep, and recoveryA hypothesis around THC’s role in rest, repair, and parasympathetic activityLessons for patients, clinicians, and anyone curious about cannabinoid use⚠️ This is not medical advice. These are individual learnings shared to help spark conversation and support evidence-based discussion.👉 Watch until the end for Chad’s conclusion on why he’ll continue CBD instead of returning to THC for now.Subscribe to stay updated on conversations that inspire higher living, deeper health, and conscious transformation.

24 de ago de 202513 min
episode APHRA Guidelines on Medical Cannabis | EP 50 artwork

APHRA Guidelines on Medical Cannabis | EP 50

Episode 50 is here, and we're discussing this one into the latest AHPRA guidelines on medical cannabis in Australia. 🤔 This has been an ongoing conversation in the industry, with concerns raised around prescribing practices, data transparency, and patient safety.We break down what these new restrictions mean for prescribers and challenge the call for more data from the regulator itself. We also tackle the sometimes contentious topic of cannabis dependence and addiction, advocating for a balanced, evidence-based approach to patient care.Join us as we explore why leading with data is crucial for the future of medical cannabis in healthcare, and why clinics with robust systems should be stepping up to lead the way. Interested in learning more about OnTracka?EMAIL: info@ontracka.comINSTAGRAM: @OnTrackaAppX/TWITTER: @OnTrackaAppDownload the OnTracka app:AppleGoogle Play#ahpra #MedicalCannabis #Australia #healthcarebusiness

14 de jul de 20256 min
episode Can Clinics Make Money? | EP 49 artwork

Can Clinics Make Money? | EP 49

In this episode of Higher Living, Chad dives into the rising buzz around clinics in Australia’s changing healthcare space. It’s been a big week of news, with Incannex Healthcare announcing a joint venture with Mind Medicine Australia, and Emyria landing a funding deal with Medibank. Clinics are back in the spotlight. But if they’re not turning a profit, why is everyone so eager to build or support them? From CDA Clinics and Montu to Eucalyptus and their proprietary tech, we take a closer look at what’s really driving the boom. Is it the prescriptions? The patient services? Or is it all about the strategy? Chad also breaks down two key models of vertical integration: owning the medications, or partnering with multiple suppliers. Each approach has major implications for patient access and long-term clinic sustainability. So, is there actually money in clinics or are we missing something bigger?

23 de jun de 20256 min